ASP-2215
| Price | $1 |
| Package | 100g |
| Min. Order: | 100g |
| Supply Ability: | G/KG/T |
| Update Time: | 2019-12-24 |
Product Details
| Product Name: ASP-2215 | CAS No.: 1254053-43-4 |
| Min. Order: 100g | Purity: 98%min |
| Supply Ability: G/KG/T | Release date: 2019/12/24 |
Cherry 316
▼
▲
ASP-2215 Basic information
▼
▲
Product Name:
ASP-2215
Synonyms:
ASP-2215;Gilteritinib;2-Pyrazinecarboxamide, 6-ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-;6-Ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-2-pyrazinecarboxamide;6-ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide;Gilteritinib (ASP2215);6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-amino)-5-((tetrahydr;ASP2215(Gilteritinib)
CAS:
1254053-43-4
MF:
C29H44N8O3
MW:
552.73
EINECS:
Product Categories:
-
Mol File:
1254053-43-4.mol
▼
▲
ASP-2215 Chemical Properties
▼
▲
Boiling point
696.9±55.0 °C(Predicted)
density
1.242±0.06 g/cm3(Predicted)
pka
14.39±0.50(Predicted)
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates：
Pharmaceutical intermediates;
OLED intermediates;
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $34.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
| $0.00/1g |
VIP1Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-08-09 | |
| $0.00/1kg |
Nanjing Fred Technology Co., Ltd
|
2023-12-12 | ||
| $0.00/1g |
VIP2Y
|
shandong perfect biotechnology co.ltd
|
2023-08-02 | |
| $0.00/1KG |
VIP3Y
|
Henan Aochuang Chemical Co.,Ltd.
|
2022-09-22 |
China- Since: 2014-12-17
- Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, H
INQUIRY